Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

FATMA ALEV TÜRKER

Profesör

Hacettepe Üniversitesi Kanser Enstitüsü Klinik Onkoloji Anabilim Dalı

  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Articles 0 YÖKSİS 0 · OpenAlex 0 Total citations 990 h-index 13 · OpenAlex Q1 articles 0 Scopus · WoS Q1 0

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 0 + YÖKSİS · co-author record: 36
h-index 13
i10-index
18
Total citations
990
Per article
27.5
FWCI
2.11
1.00 = world average
World top 1%
1
World top 10%
6

Most cited articles

  1. Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer 2022 world top 1% 490 citations
  2. Breast cancer subtypes and outcomes of central nervous system metastases 2011 world top 10% 73 citations
  3. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience 2017 world top 10% 69 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 36 articles (990 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Field ranking

YÖKSİS ?

Indexes and citation percentiles

?
TR Index 0 articles

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

0articles

Journals with publications

0 journals

No journals matched by ISSN.

Narrow down

Scopus (SJR)
Q10 Q20 Q30 Q40
WoS (JCR)
Q10 Q20 Q30 Q40
TR Index
0articles

Article list

No articles to show.

← Back to academicians